0000899243-20-019213.txt : 20200715
0000899243-20-019213.hdr.sgml : 20200715
20200715201339
ACCESSION NUMBER: 0000899243-20-019213
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200715
FILED AS OF DATE: 20200715
DATE AS OF CHANGE: 20200715
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Picularium, LLC
CENTRAL INDEX KEY: 0001817110
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39385
FILM NUMBER: 201030487
BUSINESS ADDRESS:
STREET 1: 1166 AVENUE OF THE AMERICAS, NINTH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
BUSINESS PHONE: 212-478-0000
MAIL ADDRESS:
STREET 1: 1166 AVENUE OF THE AMERICAS, NINTH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SHAW DAVID E
CENTRAL INDEX KEY: 0001023870
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39385
FILM NUMBER: 201030488
MAIL ADDRESS:
STREET 1: 120 WEST FORTY-FIFTH STREET
STREET 2: 39TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Relay Therapeutics, Inc.
CENTRAL INDEX KEY: 0001812364
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 399 BINNEY STREET
STREET 2: 2ND FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-370-8837
MAIL ADDRESS:
STREET 1: 399 BINNEY STREET
STREET 2: 2ND FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2020-07-15
0
0001812364
Relay Therapeutics, Inc.
RLAY
0001817110
Picularium, LLC
1166 AVENUE OF THE AMERICAS, 9TH FLOOR
NEW YORK
NY
10036
0
0
1
0
0001023870
SHAW DAVID E
120 WEST 45TH STREET, 39TH FLOOR
NEW YORK
NY
10036
0
0
1
0
Series A Preferred Stock, $0.001 par value per share
Common Stock, $0.001
par value per share
9999999
D
Series C Preferred Stock, $0.001 par value per share
Common Stock, $0.001 par value per share
1651471
D
Each share of Relay Therapeutics, Inc. ("Issuer") Series A Preferred Stock, $0.001 par value per share, is convertible into shares of Issuer Common Stock, $0.001 par value per share ("Common Stock"), at any time at the option of the holder. Shares of Series A Preferred Stock will automatically convert into shares of the Common Stock upon the closing of the Issuer's initial public offering of Common Stock. The current conversion rate is .281617 of a share of Common Stock for each share of Series A Preferred Stock (reflecting a one-for-3.55092 reverse stock split effected on July 8, 2020). The shares had no expiration date.
Each share of Issuer Series C Preferred Stock, $0.001 par value per share, is convertible into shares of Common Stock at any time at the option of the holder. Shares of Series C Preferred Stock will automatically convert into shares of Common Stock upon the closing of the Issuer's initial public offering of Common Stock. The current conversion rate is .2985366 of a share of Common Stock for each share of Series C Preferred Stock (reflecting a one-for-3.55092 reverse stock split effected on July 8, 2020). The shares had no expiration date.
David E. Shaw is President and sole shareholder of D. E. Shaw & Co., II, Inc., which is the sole member of D. E. Shaw Technology Development, LLC, which is the managing member of D. E Shaw Research, LLC, which is the sole member and manager of Picularium, LLC. David E. Shaw disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein, if any.
PICULARIUM, LLC, A Delaware limited liability company, By: D.E. Shaw Research, LLC, its manager, By: /s/ David E. Shaw, Name: David E. Shaw, Title: Authorized Signatory
2020-07-15
/s/ David E. Shaw, David E. Shaw
2020-07-15